Human disease isolates of serotype M4 and M22 group A streptococcus lack genes required for hyaluronic acid capsule biosynthesis

mBio

Volumn 3, Issue 6, 2012, Pages

  Flores, Anthony R ^a,b   Jewell, Brittany E ^a,b   Fittipaldi, Nahuel ^b   Beres, Stephen B ^b   Musser, James M ^b  

^a TEXAS CHILDREN S HOSPITAL   (United States)

^b HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYALURONIC ACID; GLUCURONOSYLTRANSFERASE; HYALURONAN SYNTHASE;

ARTICLE; BACTEREMIA; BACTERIAL CAPSULE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM CULTURE; BACTERIUM ISOLATE; DNA SEQUENCE; GENE SEQUENCE; GENE TARGETING; GENETIC ANALYSIS; HASABC GENE; HUMAN; IN VIVO STUDY; INFECTION; INVASIVE INFECTION; MOLECULAR GENETICS; NONHUMAN; NUCLEOTIDE SEQUENCE; PHAGOCYTE DYSFUNCTION; PHARYNGITIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEROTYPE; SOFT TISSUE INFECTION; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS GROUP A; STREPTOCOCCUS PNEUMONIAE; BIOSYNTHESIS; CLASSIFICATION; ENZYMOLOGY; GENETICS; METABOLISM; MICROBIOLOGY; REVIEW; SEROTYPING; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PYOGENES;

STREPTOCOCCUS SP. 'GROUP A';

BACTERIAL CAPSULES; BIOSYNTHETIC PATHWAYS; GENES, BACTERIAL; GLUCURONOSYLTRANSFERASE; HUMANS; HYALURONIC ACID; SEROTYPING; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES;

EID: 84872166220     PISSN: 21612129     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.00413-12     Document Type: Article

References (26)

1. Stollerman GH, Dale JB. 2008. The importance of the group a Streptococcus capsule in the pathogenesis of human infections: a historical perspective. Clin. Infect. Dis. 46:1038-1045.
2. Foley MJ, Wood WB, Jr. 1959. Studies on the pathogenicity of group A Streptococci. II. The antiphagocytic effects of the M protein and the capsular gel. J. Exp. Med. 110:617-628.
3. Kass EH, Seastone CV. 1944. The role of the mucoid polysaccharide (hyaluronic acid) in the virulence of group a hemolytic Streptococci. J. Exp. Med. 79:319-330.
4. Wessels MR, Moses AE, Goldberg JB, DiCesare TJ. 1991. Hyaluronic acid capsule is a virulence factor for mucoid group A Streptococci. Proc. Natl. Acad. Sci. U. S. A. 88:8317-8321.
5. Husmann LK, Yung DL, Hollingshead SK, Scott JR. 1997. Role of putative virulence factors of Streptococcus pyogenes in mouse models of long-term throat colonization and pneumonia. Infect. Immun. 65: 1422-1430.
6. Ashbaugh CD, Warren HB, Carey VJ, Wessels MR. 1998. Molecular analysis of the role of the group A streptococcal cysteine protease, hyaluronic acid capsule, and M protein in a murine model of human invasive soft-tissue infection. J. Clin. Invest. 102:550-560.
7. Ashbaugh CD, et al. 2000. Bacterial determinants of persistent throat colonization and the associated immune response in a primate model of human group A Streptococcal pharyngeal infection. Cell. Microbiol. 2:283-292.
8. Shea PR, et al. 2011. Distinct signatures of diversifying selection revealed by genome analysis of respiratory tract and invasive bacterial populations. Proc. Natl. Acad. Sci. U. S. A. 108:5039-5044.
9. Hernandez D, François P, Farinelli L, Osterås M, Schrenzel J. 2008. De novo bacterial genome sequencing: millions of very short reads assembled on a desktop computer. Genome Res. 18:802-809.
10. Yother J. 2011. Capsules of Streptococcus pneumoniae and other bacteria: paradigms for polysaccharide biosynthesis and regulation. Annu. Rev. Microbiol. 65:563-581.
11. Cieslewicz MJ, et al. 2005. Structural and genetic diversity of group B Streptococcus capsular polysaccharides. Infect. Immun. 73:3096-3103.
12. Steer AC, Law I, Matatolu L, Beall BW, Carapetis JR. 2009. Global emm type distribution of group A Streptococci: systematic review and implications for vaccine development. Lancet Infect. Dis. 9:611-616.
13. Shea PR, et al. 2011. Group A Streptococcus emm gene types in pharyngeal isolates, Ontario, Canada, 2002-2010. Emerg. Infect. Dis. 17:2010-2017.
14. Ashbaugh CD, Albertí S, Wessels MR. 1998. Molecular analysis of the capsule gene region of group A Streptococcus: the has AB genes are sufficient for capsule expression. J. Bacteriol. 180:4955-4959.
15. O'Loughlin RE, et al. 2007. The epidemiology of invasive group A Streptococcal infection and potential vaccine implications: United States, 2000-2004. Clin. Infect. Dis. 45:853-862.
16. Bordet J. 1907. A contribution to the study of antistreptococcal serum. John Wiley and Sons, New York, NY.
17. Hanage WP, Kaijalainen T, Saukkoriipi A, Rickcord JL, Spratt BG. 2006.Asuccessful, diverse disease-associated lineage of nontypeable pneumococci that has lost the capsular biosynthesis locus. J. Clin. Microbiol. 44:743-749.
18. Creti R, et al. 2012. Identification and molecular characterization of a S. agalactiae strain lacking the capsular locus. Eur. J. Clin. Microbiol. Infect. Dis. 31:233-235.
19. Moxon ER, Deich RA, Connelly C. 1984. Cloning of chromosomal DNA from Haemophilus influenzae. Its use for studying the expression of type b capsule and virulence. J. Clin. Invest. 73:298-306.
20. Claus H, Maiden MC, Maag R, Frosch M, Vogel U. 2002. Many carried Meningococci lack the genes required for capsule synthesis and transport. Microbiology 148:1813-1819.
21. Johnson DR, Kurlan R, Leckman J, Kaplan EL. 2010. The human immune response to streptococcal extracellular antigens: clinical, diagnostic, and potential pathogenetic implications. Clin. Infect. Dis. 50: 481-490.
22. Green NM, et al. 2005. Genetic diversity among type emm28 group A Streptococcus strains causing invasive infections and pharyngitis. J. Clin. Microbiol. 43:4083-4091.
23. Musser JM, et al. 1991. Streptococcus pyogenes causing toxic-shock-like syndrome and other invasive diseases: clonal diversity and pyrogenic exotoxin expression. Proc. Natl. Acad. Sci. U. S. A. 88:2668-2672.
24. Beres SB, Musser JM. 2007. Contribution of exogenous genetic elements to the group A Streptococcus metagenome. PLoS One 2:e800.
25. Lukomski S, et al. 2000. Nonpolar inactivation of the hypervariable Streptococcal inhibitor of complement gene (sic) in serotype M1 Streptococcus pyogenes significantly decreases mouse mucosal colonization. Infect. Immun. 68:535-542.
26. Lancefield RC. 1957. Differentiation of group A Streptococci with a common R antigen into three serological types, with special reference to the bactericidal test. J. Exp. Med. 106:525-544.